Related Experiment Video
Updated: Nov 26, 2025

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Canonical and noncanonical TGF-β signaling regulate fibrous tissue differentiation in the axial skeleton
Sade W Clayton1, Ga I Ban1,2, Cunren Liu1
1Department of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, 660 MCLM, 1918 University Blvd., Birmingham, Al, 35294-0005, USA.
Abstract:
Previously, we showed that embryonic deletion of TGF-β type 2 receptor in mouse sclerotome resulted in defects in fibrous connective tissues in the spine. Here we investigated how TGF-β regulates expression of fibrous markers: Scleraxis, Fibromodulin and Adamtsl2. We showed that TGF-β stimulated expression of Scleraxis mRNA by 2 h and Fibromodulin and Adamtsl2 mRNAs by 8 h of treatment. Regulation of Scleraxis by TGF-β did not require new protein synthesis; however, protein synthesis was required for expression of Fibromodulin and Adamtsl2 indicating the necessity of an intermediate. We subsequently showed Scleraxis was a potential intermediate for TGF-β-regulated expression of Fibromodulin and Adamtsl2. The canonical effector Smad3 was not necessary for TGF-β-mediated regulation of Scleraxis. Smad3 was necessary for regulation of Fibromodulin and Adamtsl2, but not sufficient to super-induce expression with TGF-β treatment. Next, the role of several noncanonical TGF-β pathways were tested. We found that ERK1/2 was activated by TGF-β and required to regulate expression of Scleraxis, Fibromodulin, and Adamtsl2. Based on these results, we propose a model in which TGF-β regulates Scleraxis via ERK1/2 and then Scleraxis and Smad3 cooperate to regulate Fibromodulin and Adamtsl2. These results define a novel signaling mechanism for TGFβ-mediated fibrous differentiation in sclerotome.
Insights
Transforming growth factor-beta (TGF-β) regulates fibrous connective tissue development in the spine. TGF-β signaling involves ERK1/2 and Scleraxis, with Smad3 cooperating to control Fibromodulin and Adamtsl2 expression.
Area of Science:
- Developmental Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-β) signaling is crucial for embryonic development.
- Previous studies linked TGF-β type 2 receptor to fibrous connective tissue integrity in the spine.
- The precise molecular mechanisms of TGF-β in sclerotome fibrous differentiation remain incompletely understood.
Purpose of the Study:
- To elucidate the signaling pathways by which TGF-β regulates key fibrous matrix genes in the mouse sclerotome.
- To identify the roles of canonical (Smad3) and noncanonical (ERK1/2) pathways in TGF-β-mediated gene expression.
- To determine the potential involvement of Scleraxis as an intermediate in TGF-β signaling.
Main Methods:
- Treatment of mouse sclerotome cells with TGF-β.
- Quantitative analysis of Scleraxis, Fibromodulin, and Adamtsl2 mRNA expression.
- Investigation of protein synthesis requirements using cycloheximide.
- Assessment of Smad3 and ERK1/2 pathway involvement via genetic manipulation or inhibitors.
- Analysis of gene expression in Smad3-deficient and ERK1/2-inhibited contexts.
Main Results:
- TGF-β rapidly stimulated Scleraxis mRNA and, with a delay, Fibromodulin and Adamtsl2 mRNA.
- Scleraxis regulation by TGF-β was protein synthesis-independent, while Fibromodulin and Adamtsl2 required it.
- Scleraxis acts as an intermediate for TGF-β-induced Fibromodulin and Adamtsl2 expression.
- ERK1/2 activation by TGF-β was essential for regulating all three fibrous markers.
- Smad3 was not required for Scleraxis regulation but was necessary for Fibromodulin and Adamtsl2 expression.
Conclusions:
- A novel TGF-β signaling cascade in sclerotome involves ERK1/2 activation leading to Scleraxis expression.
- Scleraxis, in conjunction with Smad3, subsequently drives the expression of Fibromodulin and Adamtsl2.
- This pathway defines a new mechanism for TGF-β in controlling fibrous differentiation during spine development.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Growth of Cartilage and Bone Tissue
Introduction to Fibroblasts
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Determination

